Actelion Ltd - Product Pipeline Review - 2015

1 of 3
Actelion Ltd - Product Pipeline Review - 2015

Summary

This, ‘Actelion Ltd - Product Pipeline Review - 2015’, provides an overview of the Actelion Ltd’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Actelion Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Actelion Ltd including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Actelion Ltd’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Actelion Ltd’s pipeline products

Reasons to buy

- Evaluate Actelion Ltd’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Actelion Ltd in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Actelion Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Actelion Ltd and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Actelion Ltd
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Actelion Ltd and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 3
List of Tables
List of Figures
Actelion Ltd Snapshot
Actelion Ltd Overview
Key Information
Key Facts
Actelion Ltd - Research and Development Overview
Key Therapeutic Areas
Actelion Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Actelion Ltd - Pipeline Products Glance
Actelion Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Actelion Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Actelion Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Actelion Ltd - Drug Profiles
selexipag
Product Description
Mechanism of Action
R&D Progress
cadazolid
Product Description
Mechanism of Action
R&D Progress
macitentan
Product Description
Mechanism of Action
R&D Progress
ponesimod
Product Description
Mechanism of Action
R&D Progress
miglustat
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Agonize S1P1 Receptor for Systemic Lupus Erythematosus
Product Description
Mechanism of Action
R&D Progress
ACT-246475
Product Description
Mechanism of Action
R&D Progress
ACT-281959
Product Description
Mechanism of Action
R&D Progress
ACT-389949
Product Description
Mechanism of Action
R&D Progress
ACT-451840
Product Description
Mechanism of Action
R&D Progress
ACT-462206
Product Description
Mechanism of Action
R&D Progress
lucerastat
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Cardiovascular Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Neurological Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit DNA Gyrase and Topoisomerase IV for Bacterial Infection
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit DNA Ligase for Staphylococcal Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Cancer
Product Description
Mechanism of Action
R&D Progress
Actelion Ltd - Pipeline Analysis
Actelion Ltd - Pipeline Products by Target
Actelion Ltd - Pipeline Products by Route of Administration
Actelion Ltd - Pipeline Products by Molecule Type
Actelion Ltd - Pipeline Products by Mechanism of Action
Actelion Ltd - Recent Pipeline Updates
Actelion Ltd - Dormant Projects
Actelion Ltd - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
almorexant
clazosentan
palosuran
Actelion Ltd - Company Statement
Actelion Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Actelion Ltd, Key Information
Actelion Ltd, Key Facts
Actelion Ltd - Pipeline by Indication, 2015
Actelion Ltd - Pipeline by Stage of Development, 2015
Actelion Ltd - Monotherapy Products in Pipeline, 2015
Actelion Ltd - Partnered Products in Pipeline, 2015
Actelion Ltd - Partnered Products/ Combination Treatment Modalities, 2015
Actelion Ltd - Pre-Registration, 2015
Actelion Ltd - Phase III, 2015
Actelion Ltd - Phase II, 2015
Actelion Ltd - Phase I, 2015
Actelion Ltd - Preclinical, 2015
Actelion Ltd - Discovery, 2015
Actelion Ltd - Pipeline by Target, 2015
Actelion Ltd - Pipeline by Route of Administration, 2015
Actelion Ltd - Pipeline by Molecule Type, 2015
Actelion Ltd - Pipeline Products by Mechanism of Action, 2015
Actelion Ltd - Recent Pipeline Updates, 2015
Actelion Ltd - Dormant Developmental Projects,2015
Actelion Ltd - Discontinued Pipeline Products, 2015
Actelion Ltd, Subsidiaries

List of Figures
Actelion Ltd - Pipeline by Top 10 Indication, 2015
Actelion Ltd - Pipeline by Stage of Development, 2015
Actelion Ltd - Monotherapy Products in Pipeline, 2015
Actelion Ltd - Partnered Products in Pipeline, 2015
Actelion Ltd - Pipeline by Top 10 Target, 2015
Actelion Ltd - Pipeline by Top 10 Route of Administration, 2015
Actelion Ltd - Pipeline by Top 10 Molecule Type, 2015
Actelion Ltd - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll